TrialSignal
Clinical trial intelligence report
Evaluation of a Mechanical Insufflation-exsufflation Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders: a Prospective, Randomized, Controlled, Multicenter Study
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT00839033-Jul 28, 2026
NCT ID
NCT00839033
Status
TERMINATED
Phase
PHASE3
Sponsor
Assistance Publique - Hôpitaux de Paris
Executive brief
Investment-Ready Snapshot
Evaluation of a Mechanical Insufflation-exsufflation Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders: a Prospective, Randomized, Controlled, Multicenter Study is a PHASE3 clinical asset sponsored by Assistance Publique
Hôpitaux de Paris in Duchenne Muscular Dystrophy, Amyotrophic Lateral Sclerosis, Neuromuscular Diseases. SEO and diligence focus: mechanical insufflation
exsufflation, Standard respiratory physiotherapy, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00839033
Indication
Duchenne Muscular Dystrophy
Modality
medical device
Target
mechanical insufflation - exsufflation, Standard respiratory physiotherapy
Intervention
mechanical insufflation - exsufflation, Standard respiratory physiotherapy
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.